Leif Bjermer
51 – 60 of 367
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
ERS/EAACI statement on adherence to international adult asthma guidelines
(
- Contribution to journal › Scientific review
-
Mark
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening : a post hoc analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
Non-exacerbating patients with COPD from a UK perspective using the galaxy model
(
- Contribution to journal › Article
-
Mark
Eosinophilic and Noneosinophilic Asthma : An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
(
- Contribution to journal › Article
-
Mark
Impaired differentiation of chronic obstructive pulmonary disease bronchial epithelial cells grown on bronchial scaffolds
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
Dual bronchodilator therapy as first-line treatment in maintenance-naïve patients with symptomatic copd : A pre-specified analysis of the emax trial
(
- Contribution to journal › Article
- 2020
-
Mark
Usability of mepolizumab single-use prefilled syringe for patient self-administration
(
- Contribution to journal › Article
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
(
- Contribution to journal › Article
-
Mark
Eosinophils, basophils, and type 2 immune microenvironments in COPD-affected lung tissue
(
- Contribution to journal › Article